Stockholm Stock Exchange | Large Cap
Vitrolife
+28.76%
Latest
+26.61%
3 months
SEBDNBHandelsbanken Capital MarketsDNB MarketsCarnegieSEB Equities

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
SEB240 SEKFeb 5
+28.76%
DNB230 SEKFeb 5
Handelsbanken Capital Markets220 SEKJan 12
DNB Markets220 SEKJan 10
Carnegie270 SEKJan 10
SEB Equities315 SEKMar -23

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia